secwatch / observer
8-K filed January 3, 2022, 6:59 PM ET ticker XTNT CIK 0001453593
leadership confidence high sentiment neutral materiality 0.50

Xtant Medical appoints Scott Neils as interim CFO; Greg Jensen departs effective Jan 3, 2022

Xtant Medical Holdings, Inc.

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed (interim)

Scott Neils

Interim Chief Financial Officer
XTNT · Xtant Medical Holdings, Inc.
Effective
2022-01-03
Filed
January 3, 2022, 6:59 PM ET
announced the appointment of Scott Neils as Interim Chief Financial Officer
Departed

Greg Jensen

Vice President, Finance and Chief Financial Officer
XTNT · Xtant Medical Holdings, Inc.
Effective
2022-01-03
Successor
Scott Neils
Filed
January 3, 2022, 6:59 PM ET
whose employment terminated effective as of January 3, 2022.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Scott Neils was appointed as Interim Chief Financial Officer at Xtant Medical Holdings, Inc..

Action
appointed
Role
Interim Chief Financial Officer
Exact text from the filing
announced the appointment of Scott Neils as Interim Chief Financial Officer
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Greg Jensen was terminated as Vice President, Finance and Chief Financial Officer at Xtant Medical Holdings, Inc..

Action
terminated
Role
Vice President, Finance and Chief Financial Officer
Exact text from the filing
whose employment terminated effective as of January 3, 2022.
View on SEC.gov

Xtant Medical Holdings, Inc. filing history →

Source: SEC EDGAR
accession 0001493152-22-000042
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.